CDY.AU · Cellmid Limited

-

Please sign in to comment on CDY.AU

1 Comment

Admin

4 years, 1 month ago

Cellmid Limited is currently in a long term downtrend where the price is trading 33.6% below its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.

Cellmid Limited's total revenue sank by 23.7% to $3M since the same quarter in the previous year.

Its net income has dropped by 71.3% to $-2M since the same quarter in the previous year.

Finally, its free cash flow fell by 24.2% to $-994K since the same quarter in the previous year.

Based on the above factors, Cellmid Limited gets an overall score of 1/5.

Sector	Personal Products
Industry	Consumer Staples
Exchange	AU
CurrencyCode	AUD
ISIN	AU000000CDY3

PE Ratio	None
Target Price	1.06
Market Cap	12M
Dividend Yield	0.0%
Beta	-1.44

ABOUT

Cellmid Limited

Cellmid Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan. It develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company markets its products through retailers and wholesalers, as well as through a direct-to-consumer, e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

CDY.AU · Cellmid Limited

-

Cellmid Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Cellmid Limited using a moving average strategy